Effect of antenatal betamethasone therapy on maternal-fetal Doppler velocimetry;Effetti della somministrazione del betametasone sulla velocimetria Doppler materno fetale

Acta Biomedica de l'Ateneo Parmense

Volumn 71, Issue SUPPL. 1, 2000, Pages 357-360

  Piazze, Juan ^a,b   Vitali, Stefano ^a   Terracina, Giovanna Madonna ^a   Anceschi, Maurizio ^a   Amici, Francesca ^a   Cignini, Pietro ^a   Cosmi, Ermelando Vinicio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMALE; FETUS HEART RATE; HUMAN; MIDDLE CEREBRAL ARTERY; PLACENTA CIRCULATION; PRENATAL DRUG EXPOSURE; PULSATILE FLOW; THIRD TRIMESTER PREGNANCY; UMBILICAL ARTERY;

BETAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; LASER-DOPPLER FLOWMETRY; PLACENTAL CIRCULATION; PREGNANCY;

EID: 6644226255     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. CHITRIT Y., CAUBEL P. HERRERO R., SCHWINTE A.L., GUILLAUMIN D., BOULANGER M.C.: Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms Br. J. Obstet. Gynaecol. 107, 501, 2000.
2. CLIFTON V.L., READ M.A., LEITCH I.M., et al.: Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphatase-mediated pathway. J. Clin. Endocrinol. Metab. 80, 2888, 1995.
3. de KLOET E.R., REUL J.M.H.M., SUTANTO W.: Corticosteroids and the brain. J. Steroid Biochem. Mol. Biol. 37, 387, 1990.
4. DERKS J.B., GIUSSANI D.A., JENKINS S.L., et al.: A comparative study of cardiovascular, endocrine and behavioral effects of betamethasone and dexamethasone administration in sheep. J. Physiol. 499, 217, 1997.
5. DERKS J.B., MULDER E.J.H., VISSER G.H.A.: The effects of maternal betamethasone administration on the fetus. Br. J. Obstet. Gynaecol. 102, 40, 1995.
6. GHEZZI F., GHIDINI A., ROMERO R. et al.: Doppler velocimetry of the middle cerebral artery in patients with preterm labor and intact membranes. J. Ultrasound. Med. 14, 361, 1995.
7. GILES W.B., MCLEAN M., DAVIES J.J., SMITH R.: Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone. Obstet. Gynecol. 87, 107, 1996.
8. KOREBRITS C., YU D.H.T., RAMIREZ M.M., MARINONI E., BOCKING A.D., CHALLIS J.R.G.: Antenatal glucocorticoid administration increases corticotropin-releasing hormone in maternal plasma. Br. J. Obstet. Gynecol. 105, 556, 1998.
9. MARI G., DETER R., Middle cerebral artery flow velocity waveforms in normal and small-for-gestational-age fetuses. Am. J. Obstet. Gynecol. 166, 1262, 1992.
10. ROBINSON B.G., EMANUEL R.I., FRIM D.M., MAJZOUB J.A.: Glucocorticosteroids stimulate expression of croticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. USA 85, 524, 1988.
11. SENAT M.V., VILLE Y.: Effect of steroids on arterial Doppler in intrauterene growth retardation fetuses. Fetal Diagn Ther. 15, 36, 2000.
12. SHERER D.M.: Prenatal ultrasonographic assessment of the middle cerebral artery: a review. Obstet. Gynecol. Surv. 52, 444, 1997.
13. VYAS S., NICOLAIDES K.H., BOWER S., CAMPBELL S.: Middle cerebral artery flow velocity waveforms in fetal hypoxemia. Br. J. Obstet. Gynecol. 97, 797, 1990.
14. WALLACE E.M., BAKER L.S.: Effect of antenatal betamethasone administration on placental vascular resistance. Lancet 353, 1404, 1999.
15. WIJNBERGER L.D.E., BILARDO C.M., HECHER K., STIGTER R.H., VISSER G.H.A.: Antenatal betamethasone and fetoplacental blood flow. Lancet 354, 256, 1999.
16. WLADIMIROFF J.W., TONGE H.M., STEWART P.A.: Doppler ultrasound assessment of cerebral blood flow in the human fetus. Br. J. Obstet. Gynecol. 93, 471, 1986.